Growth Metrics

Fulgent Genetics (FLGT) Change in Cash (2016 - 2026)

Fulgent Genetics' Change in Cash history spans 12 years, with the latest figure at -$26.8 million for Q1 2026.

  • On a quarterly basis, Change in Cash fell 320.76% to -$26.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$43.9 million, a 444.47% decrease, with the full-year FY2025 number at -$5.0 million, up 88.27% from a year prior.
  • Change in Cash hit -$26.8 million in Q1 2026 for Fulgent Genetics, up from -$67.4 million in the prior quarter.
  • Over the last five years, Change in Cash for FLGT hit a ceiling of $188.2 million in Q1 2022 and a floor of -$214.3 million in Q2 2022.
  • Historically, Change in Cash has averaged -$8.3 million across 5 years, with a median of -$2.9 million in 2024.
  • The widest YoY moves for Change in Cash: up 529.2% in 2025, down 2227.4% in 2025.
  • Tracing FLGT's Change in Cash over 5 years: stood at -$89.3 million in 2022, then skyrocketed by 115.01% to $13.4 million in 2023, then tumbled by 121.63% to -$2.9 million in 2024, then plummeted by 2227.4% to -$67.4 million in 2025, then surged by 60.27% to -$26.8 million in 2026.
  • Business Quant data shows Change in Cash for FLGT at -$26.8 million in Q1 2026, -$67.4 million in Q4 2025, and $29.8 million in Q3 2025.